Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer's disease

38Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Polyoxometalates (POMs) show significant importance in medicine due to their enzyme inhibition, antiviral and anticancer properties. In this study, some polyoxotungstates were identified as potent inhibitors of acetyl and butyrylcholinesterases. Compounds [H2W12O 42]10- and [TeW6O24]6- have the most potent acetylcholinesterase activity, exhibiting IC50 values of 0.29 ± 0.01 and 0.31 ± 0.01 μM, respectively. Whereas, compound [(O3PCH2PO3) 4W12O36]16- was a potent and selective inhibitor of butyrylcholinesterase with IC50 value of 0.18 ± 0.05 μM. In general, POMs were found to be effective cholinesterase inhibitors in terms of efficiency as well as selectivity and represent non-classical cholinesterase inhibitors. © 2012 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Iqbal, J., Barsukova-Stuckart, M., Ibrahim, M., Ali, S. U., Khan, A. A., & Kortz, U. (2013). Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer’s disease. Medicinal Chemistry Research, 22(3), 1224–1228. https://doi.org/10.1007/s00044-012-0125-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free